Clinical trial data presented at the international symposium of cannabinoid therapeutics in September suggests medical marijuana can treat the symptoms associated with ADHD in adult patients. This new data is derived from a clinical trial in which German researchers analyzed the effects of medical marijuana on 30 ADHD sufferers who found conventional therapies were ineffective in treating their symptoms. The researchers reported after cannabis was administered, study participants experienced a mitigation of their symptoms, including "improved concentration and sleep, and reduced impulsivity." In addition, twenty-two of the participants opted for only using marijuana for their symptoms, and chose to discontinue the use of pharmaceutical medications during the study period.
Currently, states that have legalized medical marijuana do not include ADHD as a qualifying condition, and few states allow medical marijuana to be recommended for the condition at a physician's discretion. The new data is significant because it provides clinical support for existing anecdotal evidence and it reveals marijuana is not only effective in treating ADHD symptoms, but also preferable to conventional therapies.
This information has been brought to you by The Daily Chronic and approved by our Chief Medical Officer.